Polar Asset Management Partners’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Polar Asset Management Partners’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-184,530	Closed	-$132K	–	1659
2021 Q3	$132K	Sell	184,530 -5,770	-3%	-$4.35K	﹤0.01%	1055
2021 Q2	$143K	Sell	190,300 -84,700	-31%	-$53.1K	﹤0.01%	986
2021 Q1	$150K	Buy	+275,000	New	+$220K	﹤0.01%	820

Other funds holding CRXTW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

ICMH

Integrity Capital Management (HK) Central, Hong Kong $19.4M AUM

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Polar Asset Management Partners's CRXTW Position: Q4 2021 in Review

Polar Asset Management Partners sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q4 2021, closing a stake of 184,530 shares — an estimated $132K sold.

Polar Asset Management Partners first reported a position in CRXTW in Q1 2021 and held it in 3 quarters. The position peaked at $150K in Q1 2021. 19 funds tracked by Wall St. Rank hold CRXTW as of Q4 2021.

Polar Asset Management Partners reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q4 2021 after selling out during the quarter.
Polar Asset Management Partners sold 184,530 Clarus Therapeutics Holdings, Inc. Warrants shares in Q4 2021, an estimated $132K.
Polar Asset Management Partners first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q1 2021 and held it in 3 quarters.
Polar Asset Management Partners's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $150K in Q1 2021.
19 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q4 2021.

Based on Polar Asset Management Partners's 13F filing for Q4 2021, filed 14 Feb 2022.